Home » Topics » Regulatory » Patents

Patents
RSS

Asahi Chem. claims sigma-receptor ligands

June 7, 1996

Compounds with high affinity for 5-HT1A and/or D2 receptors reported by E. Merck

June 7, 1996

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

CDR-grafted type III anti-CEA MAbs identified

June 7, 1996

Hoescht reports imidobisphosphonic acid derivatives

June 7, 1996

Fujisawa claims ACAT inhibitors

June 7, 1996

Indena claims colchicine derivatives

June 7, 1996

E. Merck describes immunoconjugates

June 7, 1996

Knoll describes antiarthritic and immunomodulator derivatives

June 7, 1996

Toyama reveals antiherpes compounds

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...